Researchers discovered that treating pancreatic cancer with a common chemotherapy drug makes immunotherapy more effective. Folinic acid elevates levels of two anti-cancer immune molecules within pancreatic tumors: natural killer T cells and type-I interferons. In mice, this led to a more effective immune response, slower tumor growth, and longer survival.